Dietary Caffeine, Performance and Mood: Enhancing and Restorative Effects after Controlling for Withdrawal ReversalJames J.E. · Gregg M.E. · Kane M. · Harte F.
National University of Ireland, Galway, Ireland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
This study aimed to determine whether sustained (i.e. dietary) use of caffeine has net effects on performance and mood compared with sustained abstinence, and whether dietary caffeine restores performance and mood adversely affected by sleep restriction. Participants (n = 96) alternated weekly between ingesting placebo and caffeine (1.75 mg/kg) three times daily for 4 consecutive weeks, while either rested or sleep restricted. Performance involved either a single task requiring sustained vigilance or a varied battery of brief psychomotor and cognitive tasks, and mood was assessed using the Profile of Mood States. Caffeine had no significant net enhancing effects for either performance or mood when participants were rested, and produced no net restorative effects when performance and mood were degraded by sleep restriction.
© 2005 S. Karger AG, Basel
- Bonnet MH, Arand DL: Impact of naps and caffeine on extended nocturnal performance. Physiol Behav 1994;56:103–109.
- Smith AP, Maben AL, Brockman P: The effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharmacol 1993;7:203–206.
- Walsh JK, Muelbach MJ, Humm TM, Dickens QS, Sugerman JL: Effect of caffeine on physiological sleep tendency and ability to sustain wakefulness at night. Psychopharmacology 1990;101:271–273.
- Reyner LA, Horne JA: Efficacy of a ‘functional energy drink’ in counteracting driver sleepiness. Physiol Behav 2002;75:331–335.
- James JE: Caffeine and psychomotor performance revisited. Neuropsychobiology 1995;31:202–203.
James JE: Understanding Caffeine: A Biobehavioral Analysis. Thousand Oaks, Sage, 1997.
- James JE: Acute and chronic effects of caffeine on performance, mood, headache, and sleep. Neuropsychobiology 1998;38:32–41.
- Smith AP: Caffeine, caffeine withdrawal and psychomotor performance: A reply to James. Neuropsychobiology 1995;31:200–201.
- Smith AP, Clark R, Gallagher J: Breakfast cereal and caffeinated coffee: Effects on working memory, attention, mood, and cardiovascular function. Physiol Behav 1999;67:9–17.
- Warburton DM, Bersellini E, Sweeney E: An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 2001;158:322–328.
- Yeomans MR, Ripley T, Davies LH, Rusted JM, Rogers PJ: Effects of caffeine on performance and mood depend on the level of caffeine abstinence. Psychopharmacology 2002;164:241–249.
- James JE: Does caffeine enhance or merely restore degraded psychomotor performance? Neuropsychobiology 1994;30:124–125.
- Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP: Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990;255:1123–1132.
- Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ: Caffeine self-administration and withdrawal: Incidence, individual differences and interrelationships. Drug Alcohol Depend 1993;32:239–246.
- Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG: The effects of low doses of caffeine on human performance and mood. Psychopharmacology 1987;92:308–312.
- Smit HJ, Rogers PJ: Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology 2000;152:167–173.
- Goldstein A, Kaizer S, Whitby O: Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 1969;10:489–497.
- James JE, Gregg ME: Effects of dietary caffeine on mood when rested and sleep restricted. Hum Psychopharmacol Clin Exp 2004;19:333–341.
- Lane JD, Phillips-Bute BG: Caffeine deprivation affects vigilance performance and mood. Physiol Behav 1998;65:171–175.
- Phillips-Bute BG, Lane JD: Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol Behav 1998;63:35–39.
- Richardson NJ, Rogers PJ, Elliman NA, O’Dell RJ: Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav 1995;52:313–320.
- Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ: Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology 2003;167:54–62.
James JE: Caffeine, mental performance and mood; in Watson D (ed): Performance Functional Foods. London, Woodhead, 2003, pp 168–194.
- James JE, Bruce MS, Lader MH, Scott NR: Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 1989;27:507–514.
- Parsons WD, Neims MD: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 1978;24:40–45.
- Abernethy DR, Todd EL: Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 1985;28:425–428.
James JE: Caffeine and Health. London, Academic Press, 1991.
- Pfeifer RW, Notari RE: Predicting caffeine plasma concentrations resulting from consumption of food or beverages: A simple method and its origin. Drug Intel Clin Pharm 1988;22:953–959.
- Denaro C, Brown CR, Jacob P III, Benowitz NL: Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 1991;403:273–278.
- Robertson D, Wade D, Workman R, Woosley RL, Oates JA: Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981;67:1111–1117.
- Griffiths RR, Bigelow GE, Liebson IA, O’Keeffe M, O’Leary D, Russ N: Human coffee drinking: Manipulation of concentration and caffeine dose. J Exp Anal Behav 1986;45:133–148.
- Alkaysi HN, Shiekh Salem M, El-Sayed YM: High performance liquid chromatographic analysis of caffeine concentrations in plasma and saliva. J Clin Pharm Ther 1988;13:109–115.
- Lelo A, Miners JO, Robson R, Birkett DJ: Assessment of caffeine exposure: Caffeine content of beverages caffeine intake and plasma concentrations of methylxanthines. Clin Pharmacol Ther 1986;39:54–59.
Coffield TG, Tryon W: Construct validation of actigraphic sleep measures in hospitalized depressed patients. Behav Sleep Med 2004;2;24–40.
- Wolfson AR, Carskadon MA, Acebo C, Seifer R, Fallone G, Labyak SE, Martin JL: Evidence for the validity of a sleep habits survey for adolescents. Sleep 2003;26:213–216.
Green MW, Rogers PJ: Impaired cognitive functioning during spontaneous dieting. Psych Med 1995;25:1003–1010.
McNair PM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, Educational and Industrial Testing Service, 1981.
- Azcona O, Barbanoj MJ, Torrent J, Jané F: Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 1995;40:393–400.
McNair PM, Lorr M, Droppleman LF: Profile of Mood States: Bipolar Form. San Diego, Educational and Industrial Testing Service, 1988.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.